Arena Pharmaceuticals, Inc. ARNA
With only a couple of sessions remaining before ARNA’s FDA date, we are watching this stock as closely as ever. We expect to see a significant amount of volatility from the stock this week, as we keep our eyes peeled for new press.
No matter how this all shakes out, we will want to keep ARNA on a short leash heading into the FDA date, as there are no guarantees to its performance, FDA approval or not. As we stated on Friday, smart traders may have already taken some profits off of the table.
VHGI Holdings, Inc. VHGI
We first mentioned VHGI on December 9th, and on that day, we saw a great run totaling nearly 100% from .21-.40. By January the 23rd, that high increased nearly two-fold again, running up to .746.
On Friday the stock saw abnormally high volume coupled with the 52-week low, prompting us to put VHGI back on our watchlist in anticipation of an eventual bounce. All in all, we feel the recent selloff as a new opportunity with this stock.
Evader, Inc. EVDR
We first alerted EVDR on May 2nd. On May 3rd, it hit a high of .003, yielding us a rapid 150% overnight gain!
We have witnessed EVDR’s ability to make significant leaps in just a short time period, and will thus be monitoring closely for the next wave of activity.
Thwapr, Inc. THWI
Although THWI didnt put up the performance we hoped for last week, it did hold support at .026
We noticed some newsletter coverage over the weekend from various emailers, and look forward to seeing the actvity resulting from heightened awareness.
ECDC, PROP, VPER, BKW,